Your cart is currently empty!
HemeScreen® AML
Precipio’s HemeScreen AML Panel offerings are in vitro diagnostic assays that screen for clinically actionable somatic mutations in targets of interest related to AML. This Research Use Only (RUO) assay is specifically designed to screen for mutations using High Resolution Melt Analysis in genes that are of clinical relevance: IDH1, IDH2, FLT3, KIT, CEBPA, and NPM1. The HemeScreen AML panel is a single test plate containing the components for one sample.
reaction | AML, CLL I plate, CLL reagent set |
---|